Jordan vs Papua New Guinea: Previously treated cases tested for RR-/MDR-TB
Jordan
100.0%
in 2024
Papua New Guinea
100.0%
in 2024
Jordan rank
1st
Papua New Guinea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Jordan
- Papua New Guinea
How they compare
Jordan currently reports 100.0% against 100.0% in Papua New Guinea, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Papua New Guinea ahead.
Jordan ranks 1st and Papua New Guinea ranks 1st of 180 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Jordan | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.3% | 43.3% | 3.0% | Jordan |
| 2020s | 78.0% | 100.0% | 22.0% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Jordan or Papua New Guinea?
- Jordan, at 100.0% against 100.0% in Papua New Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Jordan and Papua New Guinea?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Papua New Guinea?
- 5 years are reported by both, from 2015 to 2024.
- How do Jordan and Papua New Guinea rank globally for previously treated cases tested for rr-/mdr-tb?
- Jordan ranks 1st and Papua New Guinea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.